Author | Bijal Shah, MD, Moffit Cancer Center | OncLive

Author | Bijal Shah, MD, Moffit Cancer Center

Articles

Dr. Shah on Results of ZUMA-3 Study for ALL

June 26, 2019

Video

Bijal Shah, MD, discusses the results of the phase I/II ZUMA-3 study, which looked at using KTE-X19, an anti-CD19 CAR T-cell therapy, to treat patients with relapsed/refractory acute lymphoblastic leukemia.

x